Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Rosuvastatin for Patients at Intermediate Risk for Cardiovascular Disease
- Is Antihypertensive Therapy Warranted in Intermediate-Risk Patients?
- Improved Cardiovascular Outcomes With Combination Statin/Antihypertensive Therapy
- Prediction Rule for Benefit and Harm of Long-Term Dual Antiplatelet Therapy After PCI
- DKA With Canagliflozin in Patients With Type 1 Diabetes
- The Burden of Alcoholic and Nonalcoholic Fatty Liver Disease
- Is Earlier Patient Follow-Up After Acute MI Associated With Medication Adherence?
- Mortality Increased With Use of Psychotropic Medication in Stroke Patients
- Triglyceride Level Is Associated With Mortality in Patients With Coronary Heart Disease
- Antihypertensive Treatment at Different Blood Pressure Levels in Patients With Diabetes Mellitus